Companies involved in transgenic animals typically operate at the intersection of biotechnology, genetics, and agriculture. These companies specialize in the creation and commercialization of transgenic animals, which have been genetically modified to express specific traits or characteristics.
Jan 2024Cyagen Biosciences (US) Secured a USD 80 million Series C funding round to expand their development and production capabilities for genetically modified research models.Collaborated with leading pharmaceutical companies to develop animal models for personalized medicine research.
Bio-Rad Laboratories Launched the GeneArtâ„¢ CRISPR Knockout Kit 2.0, offering improved efficiency and flexibility for targeted gene editing in animal models.Partnered with academic institutions to explore the potential of CRISPR-Cas9 for creating novel disease models.
Creative-Biolabs (China) Established a new transgenic animal production facility in Shandong Province, China, to cater to the growing demand for research models in the region.Developed custom mouse models with humanized immune systems for preclinical cancer drug testing.
Regeneron Pharmaceuticals Received FDA approval for their Velocelumab (EYLEA®) for the treatment of diabetic macular edema (DME), produced using transgenic rabbits expressing the human VEGF-A protein.Continued research on bio-production of other therapeutic proteins in transgenic animals.
Oxitec Ltd. (UK) Successfully completed a field trial in Brazil using genetically modified mosquitoes to control the spread of mosquito-borne diseases.Partnered with government agencies in other countries to explore the potential of their technology for vector control.
List of Transgenic Animals Key Companies in the Market
Transgenic Animals Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)